Assessment of Insulin Sensitivity and Secretion with the Labelled Intravenous Glucose Tolerance Test: Improved Modelling Analysis
Overview
Authors
Affiliations
A new modelling analysis was developed to assess insulin sensitivity with a tracer-modified intravenous glucose tolerance test (IVGTT). IVGTTs were performed in 5 normal (NGT) and 7 non-insulin-dependent diabetic (NIDDM) subjects. A 300 mg/kg glucose bolus containing [6,6-(2)H2]glucose was given at time 0. After 20 min, insulin was infused for 5 min (NGT, 0.03; NIDDM, 0.05 U/kg). Concentrations of tracer, glucose, insulin and C-peptide were measured for 240 min. A circulatory model for glucose kinetics was used. Glucose clearance was assumed to depend linearly on plasma insulin concentration delayed. Model parameters were: basal glucose clearance (Cl(b)), glucose clearance at 600 pmol/l insulin concentration (Cl600), basal glucose production (Pb), basal insulin sensitivity index (BSI = Cl(b)/basal insulin concentration); incremental insulin sensitivity index (ISI = slope of the relationship between insulin concentration and glucose clearance). Insulin secretion was calculated by deconvolution of C-peptide data. Indices of basal pancreatic sensitivity (PSIb) and first (PSI1) and second-phase (PSI2) sensitivity were calculated by normalizing insulin secretion to the prevailing glucose levels. Diabetic subjects were found to be insulin resistant (BSI: 2.3 +/- 0.6 vs 0.76 +/- 0.18 ml x min(-1) x m(-2) x pmol/l(-1), p < 0.02; ISI: 0.40 +/- 0.06 vs 0.13 +/- 0.05 ml x min(-1) x m(-2) x pmol/l(-1), p < 0.02; Cl600: 333 +/- 47 vs 137 +/- 26 ml x min(-1) x m(-2), p < 0.01; NGT vs NIDDM). Pb was not elevated in NIDDM (588 +/- 169 vs 606 +/- 123 micromol x min(-1) x m(-2), NGT vs NIDDM). Hepatic insulin resistance was however present as basal glucose and insulin were higher. PSI1 was impaired in NIDDM (67 +/- 15 vs 12 +/- 7 pmol x min x m(-2) x mmol/l(-1), p < 0.02; NGT vs NIDDM). In NGT and in a subset of NIDDM subjects (n = 4), PSIb was inversely correlated with BSI (r = 0.95, p < 0.0001, log transformation). This suggests the existence of a compensatory mechanism that increases pancreatic sensitivity in the presence of insulin resistance, which is normal in some NIDDM subjects and impaired in others. In conclusion, using a simple test the present analysis provides a rich set of parameters characterizing glucose metabolism and insulin secretion, agrees with the literature, and provides some new information on the relationship between insulin sensitivity and secretion.
Borgeraas H, Hjelmesaeth J, Birkeland K, Fatima F, Grimnes J, Gulseth H BMJ Open. 2019; 9(6):e024573.
PMID: 31167860 PMC: 6561424. DOI: 10.1136/bmjopen-2018-024573.
Human insulin dynamics in women: a physiologically based model.
Weiss M, Tura A, Kautzky-Willer A, Pacini G, DArgenio D Am J Physiol Regul Integr Comp Physiol. 2015; 310(3):R268-74.
PMID: 26608654 PMC: 4796751. DOI: 10.1152/ajpregu.00113.2015.
Glucose effectiveness in obese children: relation to degree of obesity and dysglycemia.
Weiss R, Magge S, Santoro N, Giannini C, Boston R, Holder T Diabetes Care. 2015; 38(4):689-95.
PMID: 25633663 PMC: 4370330. DOI: 10.2337/dc14-2183.
Hepatic insulin clearance is the primary determinant of insulin sensitivity in the normal dog.
Ader M, Stefanovski D, Kim S, Richey J, Ionut V, Catalano K Obesity (Silver Spring). 2013; 22(5):1238-45.
PMID: 24123967 PMC: 3969862. DOI: 10.1002/oby.20625.
The identification of insulin saturation effects during the dynamic insulin sensitivity test.
Docherty P, Chase J, Hann C, Lotz T, Lin J, McAuley K Open Med Inform J. 2011; 4:141-8.
PMID: 21603183 PMC: 3096059. DOI: 10.2174/1874431101004010141.